Profile picture

Dr Shelagh Coutts

BSc, MD, MSc, FRCPC
Pronouns: She/Her

Affiliations

Professor

Cumming School of Medicine, Department of Clinical Neurosciences

Professor

Cumming School of Medicine, Department of Radiology

Professor

Cumming School of Medicine, Department of Community Health Sciences

Full Member

Hotchkiss Brain Institute

Contact information

Phone number

Office: +1 (403) 944-1594

For media enquiries, contact

Kelly Johnston
Senior Communications Specialist

Please submit your media request here

 

Background

Credentials

FRCPC, Royal college of physicians and surgeons of Canada, 2006

MRCP (UK), Royal College of Physicians, 2000

Educational Background

MBChB Medicine, University of Edinburgh, 1997

BSc Pathology, University of Edinburgh, 1995

MD University of Edinburgh, 2005

Msc (with distinction) Clinical Trials , London School of Hygiene and Tropical Medicine, 2013

Biography

Dr. Shelagh Coutts is a stroke neurologist and clinical trialist whose research focuses on improving the diagnosis and treatment of ischemic stroke and transient ischemic attack (TIA). She is a Professor in the Departments of Clinical Neurosciences, Radiology, and Community Health Sciences at the University of Calgary and Co-Director of the Calgary Stroke Program Clinical Trials Group.

Dr. Coutts’s early research demonstrated how brain and vascular imaging can identify patients at high risk of recurrent stroke following minor stroke or TIA. She led the CATCH study, which helped establish the value of imaging in early risk assessment, and was subsequently the global principal investigator of TEMPO-2, an international randomized trial of tenecteplase for patients with minor ischemic stroke and intracranial occlusion.

She now leads ACT-LATE, an adaptive trial investigating whether tenecteplase improves outcomes in patients presenting 4.5 to 24 hours after stroke onset. The trial uses widely available non-contrast CT and CT angiography to identify eligible patients, reflecting her commitment to answering practical clinical questions and making advances in stroke care accessible across diverse health-care settings.

Dr. Coutts is a member of the ACT-GLOBAL leadership group and chairs the Research Committee of the Canadian Stroke Consortium. She founded the Canadian Women in Stroke Network and serves on the Board of the World Stroke Organization. Through these roles, she strengthens international research collaborations and supports the next generation of stroke researchers.

Alongside her research, Dr. Coutts remains active in clinical care and teaching fellows, residents, and other trainees. Her work connects questions arising at the bedside with the design and delivery of large, collaborative clinical trials.

 

Awards

  • Top 40 under 40, Avenue Magazine. 2012
  • Michael J. Pessin award for Stroke Leadership , American Academy of Neurology. 2010
  • CIHR-CMAJ: Top Achievements in Health Research Awards., CIHR-CMAJ. 2011
  • Robert G. Siekert New Investigator award in Stroke , American Stroke Association . 2005
  • Distinguished clinician Scientist, HSFC, CIHR Institute of Circulatory and Respiratory Health, and AstraZeneca Canada Inc.. 2009
  • McDonald Scholarship, Heart and Stroke Foundation of Canada.. 2009